The active, transcutaneous BONEBRIDGE BCI 602 implant offers clear advantages over percutaneous BAHA (bone-anchored hearing aid) implants. Time and again, BAHAs are explanted and replaced with BONEBRIDGE. Leading ENT surgeons have reached an international consensus and established guidelines for the explantation of a BAHA followed by implantation of BCI 602.
After receiving several hearing solutions that had no lasting success, a 13-year-old from Spain received bilateral active, transcutaneous BONEBRIDGE implants. In this case report, surgeons Dr. Estefanía Berrocal and Dr. Francisco Javier Aguilar explain the challenges associated with replacing an old implant and why the BONEBRIDGE implant is their "first choice for children."
A new user interface, fully automatic 3D reconstruction and measurement of inner ear structures, simultaneous preoperative visualizations of various electrode arrays in the cochlea, support for placement planning of cochlear and bone conduction implants, and extensive postoperative analysis tools—those are just a few of the innovative features in the newest version of OTOPLAN. This software solution makes it possible to individualize hearing implant surgery—from planning the operation to the audiological fitting—like never before.
While adults who use bone conduction devices may not require auditory training, all children with hearing loss can benefit from early speech therapy and rehabilitation support. This is because, for children with hearing loss, rehabilitation involves much more than auditory training. When early detection of hearing loss is combined with early hearing device fitting and
SAMBA 2 is the latest generation audio processor for MED-EL’s active middle ear implant, VIBRANT SOUNDBRIDGE, and our bone conduction implant, BONEBRIDGE. What tests and user experiences have shown for a long time has now also been confirmed by a recent peer-reviewed publication: The sophisticated technology built into SAMBA 2 increases hearing quality and speech
.png)